SIRT1 is a histone deacetylase, which may regulate the transcriptional activity of BMAL1/CLOCK, forming a metabolic feedback loop again between the circadian clock system and metabolism (Nakahata et al., 2009
A 27 to 29 gauge needle is the clinical standard for subcutaneous peptide injection
As part of a comprehensive wellness plan, this approach can contribute to improved resilience, recovery, and overall quality of life.
Who should avoid Epithalon Absolute contraindications: Pregnancy or breastfeeding (no safety data) Active cancer diagnosis (telomerase concerns) Children and adolescents (still developing) Severe kidney or liver disease (clearance issues) Relative contraindications (use caution): Autoimmune conditions (immune stimulation could worsen) History of cancer (even if in remission - discuss with oncologist) Severe sleep disorders (pineal effects unpredictable) Taking immunosuppressants (opposing effects) Severe mental health conditions (monitor carefully) When to consult physician: Any chronic medical conditions Taking prescription medications History of adverse peptide reactions Uncertain about appropriateness Want medical monitoring during treatment Age considerations: Under 30: Questionable benefit (telomeres still long, aging minimal ) 30-50: Preventive use reasonable, moderate benefits 50+: Best candidates, age-related decline more pronounced 70+: Still beneficial but more medical monitoring advised Find peptide therapy clinics for supervised treatment at SeekPeptides
Unlike finasteride (contraindicated in women of childbearing age), copper peptides don't carry teratogenicity concerns
Therapy should therefore be directed to reduce copper toxicity
